Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oraglutide once-weekly oral semaglutide in overweight or obese adults with or without type 2 diabetes
ACTRN12626000199314Phase 2Not yet recruiting
- Sponsor
- University of Adelaide
- Start
- Mar 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of Oraglutide, sponsored by University of Adelaide. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Oraglutide
Beyond the preview
Go deeper on ACTRN12626000199314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000199314.